Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.

A vaccine being injected into a woman's upper arm

I supported with the recruitment process of participants in the COVID-19 Phase II/III Vaccine Study as a Research Nurse. The trial is jointly run by the Oxford Vaccine Group (Department of Paediatrics) and Jenner Vaccine Trials team (Nuffield Department of Medicine) at the Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital. 

Many people volunteered for the study and many healthcare workers were required to help. Jane NiedererKatherine Gordan-Quayle and I initially helped with screening, ensuring that participants were eligible and safe to take part. The study visits included gaining informed consent, which was ongoing as the protocol developed, and taking bloods samples. Other responsibilities included preparation of the blinded vaccine and observation of participants post vaccination. 

Participants' appointments were back-to-back. Each participant had different requirements depending on the arm or group they were allocated to, so we all had to be meticulous and vigilant! Recruitment completed in early December 2020 and participants will be followed up to a year after vaccination, which I will continue to help with. It was a huge combined effort of many teams, from medical students to lab and admin staff, to make this vaccine possible. 

It was very exciting to put my research experience and skills to use during the first lockdown and I will continue to work on the new upcoming COVID-19 trials

Medicines from clinical trials usually take many years to become licenced. Personally, it was truly amazing to see the analysis as the study rolled out and to receive the Oxford-Astra-Zeneca COVID-19 vaccine myself! 

I couldn't work as a front-line nurse, so it was very exciting to put my research experience and skills to use during the first lockdown and I will continue to work on the new upcoming COVID-19 trials with the Oxford Vaccine Group in 2021.  

Bhumika has recently started a new position as Clinical Research Nurse at the Oxford Respiratory Trials Unit.

Blog posts

Two races, one goal: Fundraising for cancer research

NDS researcher Dimitrios Doultsinos is set to participate in both the Athens Authentic Marathon and the Royal Parks Half Marathon in support of the CRIS Cancer Foundation.

The questions that guided me - and the answers I found

In this guest blog, Oxfordshire student Oliver Griffiths shares a reflective account of his immersive work experience at NDS. This experience transformed his uncertainty into clarity, affirming his passion for chemistry, research, and helping others. Ultimately, it has shaped the path he now envisions for his future.

Organs on the move and cells in a flask: My week at NDS

Oxford-based student Susannah Sutton delved into advanced medical science during her work experience at NDS. From organ transplantation techniques to cancer treatment innovations, she acquired hands-on skills, formed new friendships, and developed a deeper passion for research and healthcare. Read her guest blog to find out more.

Oxford Global Surgery at PAPSA 2025: Advancing paediatric surgical education across Africa

Professor Kokila Lakhoo gives a rundown of Oxford University Global Surgery Group's participation at the Pan African Pediatric Surgical Association's 2025 Congress in Abidjan, Côte d’Ivoire.

From research to impact: Presenting at the 2025 SAAPS Congress

Dr Dennis Mazingi from Oxford University Global Surgery Group reflects on his participation at the 2025 South African Association of Paediatric Surgeons (SAAPS) Congress.

Similar stories

Reflections on gratitude during lockdown

Louise King collates our words of gratitude amid the COVID-19 pandemic.